| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |